Quantum BioPharma Ltd.
QNTM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $6 | $4 | $7 | $6 |
| G&A Expenses | $9 | $13 | $16 | $23 |
| SG&A Expenses | $9 | $13 | $16 | $23 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $7 | $5 | $4 |
| Operating Expenses | $16 | $24 | $27 | $34 |
| Operating Income | -$16 | -$24 | -$27 | -$34 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1 | $6 | $1 | -$0 |
| Pre-Tax Income | -$15 | -$18 | -$27 | -$34 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$14 | -$18 | -$24 | -$35 |
| % Margin | – | – | – | – |
| EPS | -12.49 | -29.39 | -39.62 | -65.63 |
| % Growth | 57.5% | 25.8% | 39.6% | – |
| EPS Diluted | -12.49 | -29.39 | -39.62 | -65.63 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $3 | $5 | $4 |
| EBITDA | -$14 | -$16 | -$22 | -$30 |
| % Margin | – | – | – | – |